Literature DB >> 19427989

Increased likelihood of glaucoma at the same screening intraocular pressure in subjects with pseudoexfoliation: the Thessaloniki Eye Study.

Fotis Topouzis1, Alon Harris, M Roy Wilson, Archimidis Koskosas, Panayiota Founti, Fei Yu, Eleftherios Anastasopoulos, Theofanis Pappas, Anne L Coleman.   

Abstract

PURPOSE: To compare the clinical characteristics of primary open-angle glaucoma (POAG) and pseudoexfoliative glaucoma (PEXG) identified in the Thessaloniki Eye Study and to evaluate the proportion of subjects with and without pseudoexfoliation (PEX) who have glaucoma by screening intraocular pressure (IOP).
DESIGN: Cross-sectional, population-based study.
METHODS: Randomly selected subjects > or =60 years (n = 2,554) participated in the Thessaloniki Eye Study. Subjects were classified as having POAG or PEXG according to specific criteria. POAG and PEXG cases were compared for various clinical characteristics. The proportion with glaucoma among subjects with PEX and the proportion with glaucoma among subjects without PEX were estimated by IOP levels.
RESULTS: Among the clinic-visit participants (n = 2,261), 94 subjects (4.2%) had POAG and 41 (1.8%) had PEXG. The prevalence of glaucoma among subjects with PEX was 15.2% and the prevalence of glaucoma among subjects without PEX was 4.7%. In subjects without treatment, the mean IOPs were 19.8 mm Hg and 24.3 mm Hg for POAG and PEXG, respectively. For IOP level >20 mm Hg, the proportion with glaucoma among subjects with PEX was higher than that for glaucoma among subjects without PEX (37% vs 15%; P = .004), while no statistically significant difference was found for IOP level < or =20 mm Hg (2.1% vs 2.1%; P = .999), Fisher exact test.
CONCLUSIONS: In the Thessaloniki Eye Study, for screening IOP </=20 mm Hg the proportion with glaucoma was similar in subjects with and without PEX. For IOP level >20 mm Hg, the proportion with glaucoma increased highly in subjects both with and without PEX, while it was much higher among those with PEX at the same screening IOP.

Entities:  

Mesh:

Year:  2009        PMID: 19427989     DOI: 10.1016/j.ajo.2009.03.024

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  16 in total

1.  Correlation between intraocular pressure obtained with water drinking test versus modified diurnal tension curve measurement in pseudoexfoliation glaucoma.

Authors:  Penpe Gül Firat; Seyhan Dikci; İlknur Tuncer Firat; Soner Demirel; Murat Firat; Emrah Öztürk; Zarife Ekici Gök
Journal:  Int Ophthalmol       Date:  2021-04-20       Impact factor: 2.031

2.  [Pseudoexfoliation syndrome/glaucoma. Causes, consequences and management].

Authors:  U Schlötzer-Schrehardt; G O H Naumann
Journal:  Ophthalmologe       Date:  2012-10       Impact factor: 1.059

Review 3.  [New pathogenetic insights into pseudoexfoliation syndrome/glaucoma. Therapeutically relevant?].

Authors:  U Schlötzer-Schrehardt
Journal:  Ophthalmologe       Date:  2012-10       Impact factor: 1.059

4.  A comprehensive enhanced depth imaging spectral-domain optical coherence tomography analysis of pseudoexfoliation spectrum from non-glaucomatous to advanced stage glaucoma in the aspect of Bruch's membrane opening-minimum rim width.

Authors:  Mustafa Hepokur; Cansu Yuksel Elgin; Medine Gunes; Fatma Sali; Halit Oguz
Journal:  Int Ophthalmol       Date:  2022-01-05       Impact factor: 2.031

Review 5.  [Secondary open-angle glaucoma: pseudoexfoliative glaucoma, pigmentary glaucoma and neovascular glaucoma].

Authors:  Roman Greslechner; Horst Helbig; Detlev Spiegel
Journal:  Ophthalmologe       Date:  2022-04-01       Impact factor: 1.059

6.  Association of LOXL1 polymorphisms with pseudoexfoliation, glaucoma, intraocular pressure, and systemic diseases in a Greek population. The Thessaloniki eye study.

Authors:  Eleftherios Anastasopoulos; Anne L Coleman; M Roy Wilson; Janet S Sinsheimer; Fei Yu; Sokratis Katafigiotis; Panayiota Founti; Angeliki Salonikiou; Theofanis Pappas; Archimidis Koskosas; Theodora Katopodi; Alexandros Lambropoulos; Fotis Topouzis
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-06-10       Impact factor: 4.799

Review 7.  Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages.

Authors:  Gábor Holló; Andreas Katsanos; Kostas G Boboridis; Murat Irkec; Anastasios G P Konstas
Journal:  Drugs       Date:  2018-01       Impact factor: 9.546

8.  Real-life experience of using brinzolamide/brimonidine fixed drop combination in a tertiary glaucoma centre.

Authors:  Péter Kóthy; Gábor Holló
Journal:  Int Ophthalmol       Date:  2019-10-24       Impact factor: 2.031

9.  Prevalence of pseudoexfoliation syndrome and pseudoexfoliation glaucoma in Upper Egypt.

Authors:  Tarek A Shazly; Abdelsattar N Farrag; Asmaa Kamel; Ashraf K Al-Hussaini
Journal:  BMC Ophthalmol       Date:  2011-06-27       Impact factor: 2.209

10.  Pseudoexfoliation: normative data and associations. The Central India Eye and Medical Study.

Authors:  Jost B Jonas; Vinay Nangia; Arshia Matin; Krishna Bhojwani; Ajit Sinha; Anshu Khare; Shubhra Agarwal; Karishma Bhate
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.